Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis?
Relapsing pancreatitis as initial manifestation of cystic fibrosis in a young man without pulmonary disease.
Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.
Cystic Fibrosis: A Review.
Ong T, Ramsey BW.
JAMA. 2023 Jun 6;329(21):1859-1871. doi: 10.1001/jama.2023.8120.
Cystic Fibrosis.
Dickinson KM, Collaco JM.
Pediatr Rev. 2021 Feb;42(2):55-67. doi: 10.1542/pir.2019-0212.
Cystic fibrosis.
Shteinberg M, Haq IJ, Polineni D, Davies JC.
Lancet. 2021 Jun 5;397(10290):2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
Cystic fibrosis: current concepts.
López-Valdez JA, Aguilar-Alonso LA, Gándara-Quezada V, Ruiz-Rico GE, Ávila-Soledad JM, Reyes AA, Pedroza-Jiménez FD.
Bol Med Hosp Infant Mex. 2021;78(6):584-596. doi: 10.24875/BMHIM.20000372.
Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.
Agarwala P, Salzman SH.
Chest. 2020 Mar;157(3):603-611. doi: 10.1016/j.chest.2019.10.014. Epub 2019 Nov 2.
CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.
Regard L, Martin C, Burnet E, Da Silva J, Burgel PR.
Cells. 2022 May 28;11(11):1769. doi: 10.3390/cells11111769.
Cystic Fibrosis: Pathophysiology of Lung Disease.
Bergeron C, Cantin AM.
Semin Respir Crit Care Med. 2019 Dec;40(6):715-726. doi: 10.1055/s-0039-1694021. Epub 2019 Oct 28.
New drugs, new challenges in cystic fibrosis care.
Fajac I, Burgel PR, Martin C.
Eur Respir Rev. 2024 Sep 25;33(173):240045. doi: 10.1183/16000617.0045-2024. Print 2024 Jul.
CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.
Taylor-Cousar JL, Robinson PD, Shteinberg M, Downey DG.
Lancet. 2023 Sep 30;402(10408):1171-1184. doi: 10.1016/S0140-6736(23)01609-4. Epub 2023 Sep 9.
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis.
Agarwal R, Muthu V, Sehgal IS.
Semin Respir Crit Care Med. 2024 Feb;45(1):114-127. doi: 10.1055/s-0043-1776912. Epub 2023 Dec 28.
